The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia

. 2021 Dec ; 6 (4) : 663-671. [epub] 20210806

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid34328682

OBJECTIVE: Patients with tuberous sclerosis complex (TSC) present with drug-resistant epilepsy in about 60% of cases, and evaluation for epilepsy surgery may be warranted. Correct delineation of the epileptogenic zone (EZ) among multiple dysplastic lesions on MRI represents a challenging step in pre-surgical evaluation. METHODS: Two experienced neuroradiologists evaluated pre- and post-surgical MRIs of 28 epilepsy surgery patients with TSC, assessing characteristics of tubers, cysts, calcifications, and focal cortical dysplasia (FCD)-resembling lesions. Utilizing multiple metrics, we compared MRI features of the EZ-defined as the resected area in TSC patients who achieved seizure-freedom 2 years after epilepsy surgery-with features of other brain areas. Using combinatorial analysis, we identified combinations of dysplastic features that are most frequently observed in the epileptogenic zone in TSC patients. RESULTS: All TSC-associated dysplastic features were more frequently observed in the EZ than in other brain areas (increased cortical thickness, gray-white matter blurring, transmantle sign, calcifications, and tubers; Kendal's tau 0.35, 0.25, 0.27, 0.26, and 0.23, respectively; P value <.001 in all). No single feature could reliably and independently indicate the EZ in all patients. Conversely, the EZ was indicated by the presence of the combination of three of the following features: tubers, transmantle sign, increased cortical thickness, calcifications, and the largest FCD-affected area. Out of these, the largest FCD-affected area emerged as the most reliable indicator of the EZ, combined either with calcifications or tubers. SIGNIFICANCE: The epileptogenic zone in TSC patients harbors multiple dysplastic features, consistent with focal cortical dysplasia. A specific combination of these features can indicate the EZ and aid in pre-surgical MRI evaluation in epilepsy surgery candidates with TSC.

Komentář v

PubMed

Zobrazit více v PubMed

Chu‐Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia. 2010;51(7):1236–41. PubMed PMC

Kingswood JC, d'Augères GB, Belousova E, Ferreira JC, Carter T, Castellana R, et al. TuberOus SClerosis registry to increase disease Awareness (TOSCA) ‐ baseline data on 2093 patients. Orphanet J Rare Dis. 2017;12(1):1–13. PubMed PMC

Curatolo P, Nabbout R, Lagae L, Aronica E, Ferreira JC, Feucht M, et al. Management of epilepsy associated with tuberous sclerosis complex: updated clinical recommendations. Eur J Paediatr Neurol. 2018;22(5):738–48. PubMed

Bombardieri R, Pinci M, Moavero R, Cerminara C, Curatolo P. Early control of seizures improves long‐term outcome in children with tuberous sclerosis complex. Eur J. Paediatr Neurol. 2010;14(2):146–9. PubMed

Evans LT, Morse R, Roberts DW. Epilepsy surgery in tuberous sclerosis: a review. Neurosurg. Focus. 2012;32(3):E5. PubMed

Madhavan D, Schaffer S, Yankovsky A, Arzimanoglou A, Renaldo F, Zaroff CM, et al. Surgical outcome in tuberous sclerosis complex: a multicenter survey. Epilepsia. 2007;48(8):1625–8. PubMed

Liang S, Zhang J, Yang Z, Zhang S, Cui Z, Cui J, et al. Long‐term outcomes of epilepsy surgery in tuberous sclerosis complex. J Neurol. 2017;264(6):1146–54. PubMed

Arya R, Tenney JR, Horn PS, Greiner HM, Holland KD, Leach JL, et al. Long‐term outcomes of resective epilepsy surgery after invasive presurgical evaluation in children with tuberous sclerosis complex and bilateral multiple lesions. J Neurosurg Pediatr. 2015;15(1):26–33. PubMed

Cusmai R, Chiron C, Curatolo P, Dulac O, Tran‐Dinh S. Topographic comparative study of magnetic resonance imaging and electroencephalography in 34 children with tuberous sclerosis. Epilepsia. 1990;31(6):747–55. PubMed

Koh S, Jayakar P, Dunoyer C, Whiting SE, Resnick TJ, Alvarez LA, et al. Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome. Epilepsia. 2000;41(9):1206–13. PubMed

Chu‐Shore CJ, Major P, Montenegro M, Thiele E. Cyst‐like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex. Neurology. 2009;72(13):1165–9. PubMed

Chandra PS, Salamon N, Huang J, Wu JY, Koh S, Vinters HV, et al. FDG‐PET/MRI coregistration and diffusion‐tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: a preliminary report. Epilepsia. 2006;47(9):1543–9. PubMed

Jansen FE, Braun KPJ, van Nieuwenhuizen O, Huiskamp G, Vincken KL, van Huffelen AC, et al. Diffusion‐weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis. Arch Neurol. 2003;60(11):1580–4. PubMed

Jahodova A, Krsek P, Kyncl M, Jezdik P, Kudr M, Komarek V, et al. Distinctive MRI features of the epileptogenic zone in children with tuberous sclerosis. Eur J Radiol. 2014;83:703–9. PubMed

Krueger DA, Northrup H, Roberds S, Smith K, Sampson J, Korf B, et al. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49(4):255–65. PubMed PMC

Kalantari BN, Salamon N. Neuroimaging of tuberous sclerosis: spectrum of pathologic findings and frontiers in imaging. Am J Roentgenol. 2008;190(5):304–9. PubMed

Krishnan ML, Commowick O, Jeste SS, Weisenfeld N, Hans A, Gregas MC, et al. Diffusion features of white matter in tuberous sclerosis with tractography. Pediatr Neurol. 2010;42(2):101–6. PubMed PMC

Gallagher A, Chu‐Shore CJ, Montenegro MA, Major P, Costello DJ, Lyczkowski DA, et al. Associations between electroencephalographic and magnetic resonance imaging findings in tuberous sclerosis complex. Epilepsy Res. 2009;87(2–3):197–202. PubMed

Barkovich AJ, Kuzniecky RI, Bollen AW, Grant PE. Focal transmantle dysplasia: a specific malformation of cortical development. Neurology. 1997;49(4):1148–52. PubMed

Martin KR, Zhou W, Bowman MJ, Shih J, Au KS, Dittenhafer‐Reed KE, et al. The genomic landscape of tuberous sclerosis complex. Nat Commun. 2017;8(1):1–13. PubMed PMC

D'Gama AM, Woodworth MB, Hossain AA, Bizzotto S, Hatem NE, Lacoursiere CM, et al. Somatic mutations activating the mTORpathway in dorsal telencephalic progenitors cause a continuum of corticaldysplasias. Cell Rep. 2017;21(13):3754–66. PubMed PMC

Baldassari S, Ribierre T, Marsan E, Adle‐Biassette H, Ferrand‐Sorbets S, Bulteau C, et al. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Acta Neuropathol. 2019;138(6):885–900. PubMed PMC

Baldassari S, Picard F, Verbeek NE, van Kempen M, Brilstra EH, Lesca G, et al. The landscape of epilepsy‐related GATOR1 variants. Genet Med. 2019;21(2):398–408. PubMed PMC

Wong M. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations. Exp Neurol. 2013;244:22–6. PubMed PMC

Curatolo P, Moavero R, van Scheppingen J, Aronica E. mTOR dysregulation and tuberous sclerosis‐related epilepsy. Expert Rev Neurother. 2018;18(3):185–201. PubMed

Krsek P, Jahodova A, Kyncl M, Kudr M, Komarek V, Jezdik P, et al. Predictors of seizure‐free outcome after epilepsy surgery for pediatric tuberous sclerosis complex. Epilepsia. 2013;54(11):1913–21. PubMed

Jansen FE, Van Huffelen AC, Van Rijen PC, Leijten FSS, Jennekens‐Schinkel A, Gosselaar P, et al. Epilepsy surgery in tuberous sclerosis: the Dutch experience. Seizure. 2007;16(5):445–53. PubMed

Rosenow F, Lüders H. Presurgical evaluation of epilepsy. Brain. 2001;124:1683–700. PubMed

Baud MO, Perneger T, Rácz A, Pensel MC, Elger C, Rydenhag B, et al. European trends in epilepsy surgery. Neurology. 2018;91(2):e96–106. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...